A citation-based method for searching scientific literature

Ziyu Wen, Caijun Sun. Vaccines (Basel) 2020
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.
Kathryn E Stephenson, Kshitij Wagh, Bette Korber, Dan H Barouch. Annu Rev Immunol 2020
45
66

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
Susan P Buchbinder, Devan V Mehrotra, Ann Duerr, Daniel W Fitzgerald, Robin Mogg, David Li, Peter B Gilbert, Javier R Lama, Michael Marmor, Carlos Del Rio,[...]. Lancet 2008
66

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Lawrence Corey, Peter B Gilbert, Michal Juraska, David C Montefiori, Lynn Morris, Shelly T Karuna, Srilatha Edupuganti, Nyaradzo M Mgodi, Allan C deCamp, Erika Rudnicki,[...]. N Engl J Med 2021
128
66

Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies.
Matthew R Gardner, Ina Fetzer, Lisa M Kattenhorn, Meredith E Davis-Gardner, Amber S Zhou, Barnett Alfant, Jesse A Weber, Hema R Kondur, Jose M Martinez-Navio, Sebastian P Fuchs,[...]. Mol Ther 2019
29
33

Broadly Neutralizing Antibodies for HIV Prevention.
Shelly T Karuna, Lawrence Corey. Annu Rev Med 2020
29
33

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
Rebecca M Lynch, Eli Boritz, Emily E Coates, Adam DeZure, Patrick Madden, Pamela Costner, Mary E Enama, Sarah Plummer, Lasonji Holman, Cynthia S Hendel,[...]. Sci Transl Med 2015
322
33

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.
Frances H Priddy, David J M Lewis, Huub C Gelderblom, Hana Hassanin, Claire Streatfield, Celia LaBranche, Jonathan Hare, Josephine H Cox, Len Dally, Daryl Bendel,[...]. Lancet HIV 2019
57
33

An HIV-1 vaccine based on bacterium-like particles elicits Env-specific mucosal immune responses.
Jinpeng Bi, Fangshen Li, Mo Zhang, Huaiyu Wang, Jingcai Lu, Yong Zhang, Hong Ling, Jiaye Wang, Feng Gao, Wei Kong,[...]. Immunol Lett 2020
6
33

Engineering antibody-based molecules for HIV treatment and cure.
Marina Tuyishime, Guido Ferrari. Curr Opin HIV AIDS 2020
5
33

Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.
Daniel R Kuritzkes, Jeffrey Jacobson, William G Powderly, Eliot Godofsky, Edwin DeJesus, Frances Haas, Keith A Reimann, Jeffrey L Larson, Patrice O Yarbough, Valentin Curt,[...]. J Infect Dis 2004
149
33

Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.
Marina Caskey, Florian Klein, Michel C Nussenzweig. Nat Med 2019
135
33



Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.
Peter B Gilbert, James O Berger, Donald Stablein, Stephen Becker, Max Essex, Scott M Hammer, Jerome H Kim, Victor G Degruttola. J Infect Dis 2011
68
33

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption.
Denise C Hsu, Alexandra Schuetz, Rawiwan Imerbsin, Decha Silsorn, Amarendra Pegu, Dutsadee Inthawong, Jumpol Sopanaporn, Pornsuk Visudhiphan, Weerawan Chuenarom, Boot Keawboon,[...]. PLoS Pathog 2021
16
33

Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV.
Sigrid D'haese, Céline Lacroix, Felipe Garcia, Montserrat Plana, Simona Ruta, Guido Vanham, Bernard Verrier, Joeri L Aerts. J Control Release 2021
8
33

Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle.
Nicole K Paulk, Katja Pekrun, Gregory W Charville, Katie Maguire-Nguyen, Michael N Wosczyna, Jianpeng Xu, Yue Zhang, Leszek Lisowski, Bryan Yoo, Jose G Vilches-Moure,[...]. Mol Ther Methods Clin Dev 2018
13
33


Antibody 10-1074 suppresses viremia in HIV-1-infected individuals.
Marina Caskey, Till Schoofs, Henning Gruell, Allison Settler, Theodora Karagounis, Edward F Kreider, Ben Murrell, Nico Pfeifer, Lilian Nogueira, Thiago Y Oliveira,[...]. Nat Med 2017
298
33


Critical design criteria for engineering a nanoparticulate HIV-1 vaccine.
Stefanie Thalhauser, David Peterhoff, Ralf Wagner, Miriam Breunig. J Control Release 2020
11
33

Antibody-based protection against HIV infection by vectored immunoprophylaxis.
Alejandro B Balazs, Joyce Chen, Christin M Hong, Dinesh S Rao, Lili Yang, David Baltimore. Nature 2011
403
33

AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region.
Fiona T van den Berg, Nigel A Makoah, Stuart A Ali, Tristan A Scott, Rutendo E Mapengo, Lorraine Z Mutsvunguma, Nonhlanhla N Mkhize, Bronwen E Lambson, Prudence D Kgagudi, Carol Crowther,[...]. Mol Ther Methods Clin Dev 2019
21
33

Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
Lauriel F Earley, Laura M Conatser, Victoria M Lue, Amanda L Dobbins, Chengwen Li, Matthew L Hirsch, R Jude Samulski. Hum Gene Ther 2020
21
33

Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
Magalie Penaud-Budloo, Caroline Le Guiner, Ali Nowrouzi, Alice Toromanoff, Yan Chérel, Pierre Chenuaud, Manfred Schmidt, Christof von Kalle, Fabienne Rolling, Philippe Moullier,[...]. J Virol 2008
159
33

Constructing and evaluating caspase-activatable adeno-associated virus vector for gene delivery to the injured heart.
Mitchell J Brun, Kefan Song, Byunguk Kang, Cooper Lueck, Weitong Chen, Kaitlyn Thatcher, Erhe Gao, Walter J Koch, Joy Lincoln, Sudarsan Rajan,[...]. J Control Release 2020
2
50

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.
Johannes F Scheid, Joshua A Horwitz, Yotam Bar-On, Edward F Kreider, Ching-Lan Lu, Julio C C Lorenzi, Anna Feldmann, Malte Braunschweig, Lilian Nogueira, Thiago Oliveira,[...]. Nature 2016
316
33

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.
Katharine J Bar, Michael C Sneller, Linda J Harrison, J Shawn Justement, Edgar T Overton, Mary E Petrone, D Brenda Salantes, Catherine A Seamon, Benjamin Scheinfeld, Richard W Kwan,[...]. N Engl J Med 2016
300
33

Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice.
Xilin Wu, Jia Guo, Mengyue Niu, Minghui An, Li Liu, Hui Wang, Xia Jin, Qi Zhang, Ka Shing Lam, Tongjin Wu,[...]. J Clin Invest 2018
31
33

Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow.
Raoufeh Ahamadi-Fesharaki, Abolfazl Fateh, Farzam Vaziri, Ghasem Solgi, Seyed Davar Siadat, Fereidoun Mahboudi, Fatemeh Rahimi-Jamnani. Mol Ther Oncolytics 2019
27
33

Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials.
Tayebeh Rezaei, Saeed Khalili, Behzad Baradaran, Jafar Mosafer, Sarah Rezaei, Ahad Mokhtarzadeh, Miguel de la Guardia. J Control Release 2019
18
33

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.
Hugh C Welles, Madeleine F Jennewein, Rosemarie D Mason, Sandeep Narpala, Lingshu Wang, Cheng Cheng, Yi Zhang, John-Paul Todd, Jeffrey D Lifson, Alejandro B Balazs,[...]. PLoS Pathog 2018
25
33

Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs.
Johannes Brozy, Erika Schlaepfer, Christina K S Mueller, Mary-Aude Rochat, Silvana K Rampini, Renier Myburgh, Tobias Raum, Peter Kufer, Patrick A Baeuerle, Markus Muenz,[...]. J Virol 2018
19
33

A viral assembly factor promotes AAV2 capsid formation in the nucleolus.
Florian Sonntag, Kristin Schmidt, Jürgen A Kleinschmidt. Proc Natl Acad Sci U S A 2010
222
33

Expression of HIV-1 broadly neutralizing antibodies mediated by recombinant adeno-associated virus 8 in vitro and in vivo.
Yongjiao Yu, Lu Fu, Xiaoyu Jiang, Shanshan Guan, Ziyu Kuai, Wei Kong, Yuhua Shi, Yaming Shan. Mol Immunol 2016
3
33

Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform.
J G Tong, A C Evans, M L Ho, C M Guenther, M J Brun, J Judd, E Wu, J Suh. J Control Release 2019
8
33

Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
Brinda Emu, Jeffrey Fessel, Shannon Schrader, Princy Kumar, Gary Richmond, Sandra Win, Steven Weinheimer, Christian Marsolais, Stanley Lewis. N Engl J Med 2018
108
33

Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1.
Tumelo Moshoette, Stuart Alvaro Ali, Maria Antonia Papathanasopoulos, Mark Andrew Killick. Retrovirology 2019
10
33

Engineering adeno-associated viruses for clinical gene therapy.
Melissa A Kotterman, David V Schaffer. Nat Rev Genet 2014
474
33

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.
Marina Caskey, Florian Klein, Julio C C Lorenzi, Michael S Seaman, Anthony P West, Noreen Buckley, Gisela Kremer, Lilian Nogueira, Malte Braunschweig, Johannes F Scheid,[...]. Nature 2015
528
33

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.
Matthew R Gardner, Lisa M Kattenhorn, Hema R Kondur, Markus von Schaewen, Tatyana Dorfman, Jessica J Chiang, Kevin G Haworth, Julie M Decker, Michael D Alpert, Charles C Bailey,[...]. Nature 2015
208
33


Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.
Rohith Palli, Kelly E Seaton, Michael S Piepenbrink, John Hural, Paul A Goepfert, Fatima Laher, Susan P Buchbinder, Gavin Churchyard, Glenda E Gray, Harriet L Robinson,[...]. Sci Rep 2020
5
33

Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers.
Javier Guenaga, Viktoriya Dubrovskaya, Natalia de Val, Shailendra K Sharma, Barbara Carrette, Andrew B Ward, Richard T Wyatt. J Virol 2015
90
33

Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes.
Rajesh P Ringe, Gabriel Ozorowski, Anila Yasmeen, Albert Cupo, Victor M Cruz Portillo, Pavel Pugach, Michael Golabek, Kimmo Rantalainen, Lauren G Holden, Christopher A Cottrell,[...]. J Virol 2017
23
33

Experimental evaluation of the cross-protection between Sheeppox and bovine Lumpy skin vaccines.
Jihane Hamdi, Zahra Bamouh, Mohammed Jazouli, Zineb Boumart, Khalid Omari Tadlaoui, Ouafaa Fassi Fihri, Mehdi El Harrak. Sci Rep 2020
15
33

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles.
Rosamund Chapman, Michiel van Diepen, Shireen Galant, Elizabeth Kruse, Emmanuel Margolin, Phindile Ximba, Tandile Hermanus, Penny Moore, Nicola Douglass, Anna-Lise Williamson,[...]. Vaccines (Basel) 2020
7
33

Poxvirus recombinant vaccines.
E Paoletti. Ann N Y Acad Sci 1990
10
33


Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages.
Gerald K Chege, Craig H Adams, Alana T Keyser, Valerie Bekker, Lynn Morris, Francois J Villinger, Anna-Lise Williamson, Rosamund E Chapman. Viruses 2021
1
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.